Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Varex Imaging CorpVREX · Entity 5135 | SVP and GM, X-Ray Sources | December 15, 2025 | December 17, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Varex Imaging Corp
Report date December 15, 2025 · Filed December 17, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 4,178 |
Reported balance
After 2025-12-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-12-15 · Grant · Acquired 2,565 · Balance 4,178 F1: Each PSU represents a contingent right to receive one share of Varex Imaging common stock, subject to the achievement of applicable performance criteria. F2: On December 10, 2023, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2026, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 3,134 |
Reported balance
After 2025-12-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-12-15 · Grant · Acquired 3,134 · Balance 3,134 F1: Each PSU represents a contingent right to receive one share of Varex Imaging common stock, subject to the achievement of applicable performance criteria. F3: On December 10, 2024, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2027, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each PSU represents a contingent right to receive one share of Varex Imaging common stock, subject to the achievement of applicable performance criteria.
F2: On December 10, 2023, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2026, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date.
F3: On December 10, 2024, the Reporting Person was granted PSU's, the vesting of which is subject to the achievement of certain performance criteria. The number of shares reported represents the number of PSU's that were earned for fiscal year 2025 as a result of the achievement of such performance criteria during fiscal year 2025. Following the completion of fiscal year 2027, the Compensation Committee will certify and approve the total number of PSU's that were earned, and such PSU's will vest subject to the Reporting Person being employed through the vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 14, 2020 Filed Feb 19, 2020 20:37 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionRestricted Stock Units · Derivative | 1,354 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000027 · wf-form4_158216262470727.xml · derivative · entry 7 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,062 Underlying: Common Stock · 1,354 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F5 · derivative.exercise_date: These Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.expiration_date: These Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 20:37 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionRestricted Stock Units · Derivative | 1,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000027 · wf-form4_158216262470727.xml · derivative · entry 6 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,293 Underlying: Common Stock · 1,147 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: These Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: These Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 20:37 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionRestricted Stock Units · Derivative | 1,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000027 · wf-form4_158216262470727.xml · derivative · entry 5 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,521 Underlying: Common Stock · 1,520 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Restricted Stock Units granted on February 16, 2017 vest 25% each year for four years beginning on February 15, 2018. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.expiration_date: These Restricted Stock Units granted on February 16, 2017 vest 25% each year for four years beginning on February 15, 2018. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 20:37 UTC | Varex Imaging Corp VREX · Entity 5135 | Tax withholdingCommon Stock | 1,958 | $25.89 | $50,692.62 |
DisclosureSEC source: 0001681622-20-000027 · wf-form4_158216262470727.xml · nonDerivative · entry 4 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,502 F2 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 20:37 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 1,354 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000027 · wf-form4_158216262470727.xml · nonDerivative · entry 3 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,460 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 20:37 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 1,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000027 · wf-form4_158216262470727.xml · nonDerivative · entry 2 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,106 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 20:37 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 1,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-20-000027 · wf-form4_158216262470727.xml · nonDerivative · entry 1 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,959 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 17:50 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 13,530 | $0.00 Strike: $22.84 | $0.00 |
DisclosureSEC source: 0001681622-19-000076 · wf-form4_157299420093544.xml · derivative · entry 3 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,530 shares Expires 2019-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted in connection with the spin-off from Varian Medical Systems, Inc. and were immediately exercisable because they replaced Varian options that had previously vested. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 17:50 UTC | Varex Imaging Corp VREX · Entity 5135 | SaleCommon Stock | 13,530 | $31.02 | $419,700.60 |
DisclosureSEC source: 0001681622-19-000076 · wf-form4_157299420093544.xml · nonDerivative · entry 2 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,439 F2 · price: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on May 20, 2019. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.19 to $31.39. The reporting person undertakes to provide Varex Imaging Corporation, any security holder of Varex Imaging Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 17:50 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 13,530 | $22.84 | $309,025.20 |
DisclosureSEC source: 0001681622-19-000076 · wf-form4_157299420093544.xml · nonDerivative · entry 1 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,969 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 939 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 19:56 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 16,699 | $0.00 Strike: $31.42 | $0.00 |
DisclosureSEC source: 0001681622-19-000034 · wf-form4_155071055112694.xml · derivative · entry 9 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,699 Underlying: Common Stock · 16,699 shares Expires 2026-02-15 F8 · derivative.exercise_date: This Non-Qualified Stock Option is subject to a four-year vesting schedule. 25% of the total number of options vests one year from grant date, and the remaining options vests monthly thereafter on a pro rata basis. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 19:56 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantRestricted Stock Units · Derivative | 5,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-19-000034 · wf-form4_155071055112694.xml · derivative · entry 8 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,416 Underlying: Common Stock · 5,416 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F7 · derivative.exercise_date: The Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date. F7 · derivative.expiration_date: The Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 19:56 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionRestricted Stock Units · Derivative | 1,146 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-19-000034 · wf-form4_155071055112694.xml · derivative · entry 7 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,440 Underlying: Common Stock · 1,146 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F6 · derivative.exercise_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date. F6 · derivative.expiration_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 19:56 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionRestricted Stock Units · Derivative | 1,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-19-000034 · wf-form4_155071055112694.xml · derivative · entry 6 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,041 Underlying: Common Stock · 1,520 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F5 · derivative.exercise_date: These Restricted Stock Units vest 25% each year for four years with the first vesting date being February 15, 2018. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.expiration_date: These Restricted Stock Units vest 25% each year for four years with the first vesting date being February 15, 2018. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 19:56 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionRestricted Stock Units · Derivative | 1,767 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-19-000034 · wf-form4_155071055112694.xml · derivative · entry 5 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,767 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: These Restricted Stock Units vest in three equal annual installments with the first vesting date being February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: These Restricted Stock Units vest in three equal annual installments with the first vesting date being February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 19:56 UTC | Varex Imaging Corp VREX · Entity 5135 | Tax withholdingCommon Stock | 2,067 | $31.42 | $64,945.14 |
DisclosureSEC source: 0001681622-19-000034 · wf-form4_155071055112694.xml · nonDerivative · entry 4 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 F3 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 19:56 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 1,146 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-19-000034 · wf-form4_155071055112694.xml · nonDerivative · entry 3 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,567 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 19:56 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 1,520 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-19-000034 · wf-form4_155071055112694.xml · nonDerivative · entry 2 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,421 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 19:56 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 1,767 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-19-000034 · wf-form4_155071055112694.xml · nonDerivative · entry 1 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F2 · balance_after: Includes 345 shares acquired under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 18:44 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 11,155 | $0.00 Strike: $19.21 | $0.00 |
DisclosureSEC source: 0001681622-18-000035 · wf-form4_153731067861809.xml · derivative · entry 2 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,155 shares Expires 2018-11-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted in connection with Varex's spin-off from Varian Medical Systems, Inc. and were immediately exercisable because they replaced Varian options that had previously vested. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 18:44 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 11,155 | $19.21 | $214,287.55 |
DisclosureSEC source: 0001681622-18-000035 · wf-form4_153731067861809.xml · nonDerivative · entry 1 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,789 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount of securities beneficially owned at end of reporting period reflect 564 shares purchased on on April 27, 2018 under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan. Also includes 20 shares inadvertently omitted from a prior Form 4 filing. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 20:51 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 14,409 | $0.00 Strike: $37.10 | $0.00 |
DisclosureSEC source: 0001214659-18-001421 · marketforms-41070.xml · derivative · entry 9 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,409 Underlying: Common Stock · 14,409 shares Expires 2025-02-15 F8 · derivative.exercise_date: This Non-Qualified Stock Option is subject to a four-year vesting schedule. 25% of the total number of options vests one year from grant date, and the remaining options vests monthly thereafter on a pro rata basis. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 20:51 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantRestricted Stock Units · Derivative | 4,586 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-18-001421 · marketforms-41070.xml · derivative · entry 8 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,586 Underlying: Common Stock · 4,586 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F7 · derivative.exercise_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date. F7 · derivative.expiration_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 20:51 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionRestricted Stock Units · Derivative | 1,644 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-18-001421 · marketforms-41070.xml · derivative · entry 7 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,644 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F6 · derivative.exercise_date: These Restricted Stock Units vest in two equal annual installments with the first vesting date being February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F6 · derivative.expiration_date: These Restricted Stock Units vest in two equal annual installments with the first vesting date being February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 20:51 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionRestricted Stock Units · Derivative | 1,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-18-001421 · marketforms-41070.xml · derivative · entry 6 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,767 Underlying: Common Stock · 1,766 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F5 · derivative.exercise_date: These Restricted Stock Units vest in three equal annual installments with the first vesting date being February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.expiration_date: These Restricted Stock Units vest in three equal annual installments with the first vesting date being February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 20:51 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionRestricted Stock Units · Derivative | 1,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-18-001421 · marketforms-41070.xml · derivative · entry 5 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,561 Underlying: Common Stock · 1,520 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: These Restricted Stock Units vest 25% each year for four years with the first vesting date being February 15, 2018. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: These Restricted Stock Units vest 25% each year for four years with the first vesting date being February 15, 2018. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 20:51 UTC | Varex Imaging Corp VREX · Entity 5135 | Tax withholdingCommon Stock | 2,246 | $37.10 | $83,326.60 |
DisclosureSEC source: 0001214659-18-001421 · marketforms-41070.xml · nonDerivative · entry 4 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,050 F3 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 20:51 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 1,644 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-18-001421 · marketforms-41070.xml · nonDerivative · entry 3 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,296 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 20:51 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 1,766 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-18-001421 · marketforms-41070.xml · nonDerivative · entry 2 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,652 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 20:51 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 1,520 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-18-001421 · marketforms-41070.xml · nonDerivative · entry 1 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,886 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F2 · balance_after: Includes 548 shares acquired under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan Read SEC document |
| April 17, 2017 Filed Apr 19, 2017 20:56 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 18,089 | $0.00 Strike: $17.53 | $0.00 |
DisclosureSEC source: 0001214659-17-002625 · marketforms-38574.xml · derivative · entry 3 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,089 shares Expires 2017-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 16, 2017. Read SEC document |
| April 17, 2017 Filed Apr 19, 2017 20:56 UTC | Varex Imaging Corp VREX · Entity 5135 | SaleCommon Stock | 18,089 | $33.54 | $606,663.46 |
DisclosureSEC source: 0001214659-17-002625 · marketforms-38574.xml · nonDerivative · entry 2 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,348 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.31 to $33.96. Read SEC document |
| April 17, 2017 Filed Apr 19, 2017 20:56 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 18,089 | $17.53 | $317,100.17 |
DisclosureSEC source: 0001214659-17-002625 · marketforms-38574.xml · nonDerivative · entry 1 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,437 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · balance_after: Includes 19,818 shares inadvertently omitted from a prior Form 4 filing. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 20:34 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 64,384 | $0.00 Strike: $31.08 | $0.00 |
DisclosureSEC source: 0001214659-17-001265 · marketforms-37979.xml · derivative · entry 11 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,384 Underlying: Common Stock · 64,384 shares Expires 2024-02-16 F7 · derivative.exercise_date: This Non-Qualifed Stock Option is subject to a four-year vesting schedule. 25% of the total number of shares vests one year from grant date, and the remaining 75% vests monthly thereafter. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 20:34 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantRestricted Stock Units · Derivative | 6,081 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-001265 · marketforms-37979.xml · derivative · entry 10 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,278 Underlying: Common Stock · 6,081 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F6 · derivative.exercise_date: The Restricted Stock Units granted on February 16, 2017 vest 25% each year for four years beginning on February 15, 2018. Vested shares will be delivered to the reporting person upon vest date. F6 · derivative.expiration_date: The Restricted Stock Units granted on February 16, 2017 vest 25% each year for four years beginning on February 15, 2018. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 20:34 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionRestricted Stock Units · Derivative | 1,767 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-001265 · marketforms-37979.xml · derivative · entry 9 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,533 Underlying: Common St · 1,767 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F5 · derivative.exercise_date: These Restricted Stock Units vest in three equal annual installments beginning February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.expiration_date: These Restricted Stock Units vest in three equal annual installments beginning February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 20:34 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionRestricted Stock Units · Derivative | 1,664 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-001265 · marketforms-37979.xml · derivative · entry 8 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,664 Underlying: Common Stock · 1,664 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: These Restricted Stock Units vest in two equal annual installments beginning February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: These Restricted Stock Units vest in two equal annual installments beginning February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 20:34 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionRestricted Stock Units · Derivative | 4,323 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-001265 · marketforms-37979.xml · derivative · entry 7 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,323 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Restricted Stock Units vest February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.expiration_date: These Restricted Stock Units vest February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 20:34 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionRestricted Stock Units · Derivative | 2,002 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-001265 · marketforms-37979.xml · derivative · entry 6 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,002 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Restricted Stock Units vest February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.expiration_date: These Restricted Stock Units vest February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 20:34 UTC | Varex Imaging Corp VREX · Entity 5135 | Tax withholdingCommon Stock | 3,226 | $29.93 | $96,554.18 |
DisclosureSEC source: 0001214659-17-001265 · marketforms-37979.xml · nonDerivative · entry 5 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,530 F2 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 20:34 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 1,767 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-17-001265 · marketforms-37979.xml · nonDerivative · entry 4 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,756 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 20:34 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 1,664 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-17-001265 · marketforms-37979.xml · nonDerivative · entry 3 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,989 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 20:34 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 4,323 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-17-001265 · marketforms-37979.xml · nonDerivative · entry 2 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 15, 2017 Filed Feb 17, 2017 20:34 UTC | Varex Imaging Corp VREX · Entity 5135 | Exercise / conversionCommon Stock | 2,002 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-17-001265 · marketforms-37979.xml · nonDerivative · entry 1 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,002 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| January 28, 2017 Filed Jan 31, 2017 21:02 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantRestricted Stock Units · Derivative | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000581 · marketforms-37690.xml · derivative · entry 10 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires not disclosed F8 · derivative.exercise_price: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F8 · shares: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F11 · derivative.exercise_date: These RSUs vest in three equal annual installments beginning on February 12, 2017. Vested shares will be delivered to the reporting person upon vest date. F11 · derivative.expiration_date: These RSUs vest in three equal annual installments beginning on February 12, 2017. Vested shares will be delivered to the reporting person upon vest date. F8 · derivative.underlying_shares: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F8 · balance_after: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document |
| January 28, 2017 Filed Jan 31, 2017 21:02 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantRestricted Stock Units · Derivative | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000581 · marketforms-37690.xml · derivative · entry 9 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires not disclosed F8 · derivative.exercise_price: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F8 · shares: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F10 · derivative.exercise_date: These RSUs vest in two equal installments beginning on February 13, 2017. Vested shares will be delivered to the reporting person upon vest date. F10 · derivative.expiration_date: These RSUs vest in two equal installments beginning on February 13, 2017. Vested shares will be delivered to the reporting person upon vest date. F8 · derivative.underlying_shares: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F8 · balance_after: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document |
| January 28, 2017 Filed Jan 31, 2017 21:02 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantRestricted Stock Units · Derivative | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000581 · marketforms-37690.xml · derivative · entry 8 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires not disclosed F8 · derivative.exercise_price: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F8 · shares: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F9 · derivative.exercise_date: These RSUs vest February 21, 2017. Vested shares will be delivered to the reporting person upon vest date. F9 · derivative.expiration_date: These RSUs vest February 21, 2017. Vested shares will be delivered to the reporting person upon vest date. F8 · derivative.underlying_shares: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F8 · balance_after: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document |
| January 28, 2017 Filed Jan 31, 2017 21:02 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantRestricted Stock Units · Derivative | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000581 · marketforms-37690.xml · derivative · entry 7 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires not disclosed F8 · derivative.exercise_price: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F8 · shares: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F9 · derivative.exercise_date: These RSUs vest February 21, 2017. Vested shares will be delivered to the reporting person upon vest date. F9 · derivative.expiration_date: These RSUs vest February 21, 2017. Vested shares will be delivered to the reporting person upon vest date. F8 · derivative.underlying_shares: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F8 · balance_after: In connection with the Spin-off, each outstanding deferred stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document |
| January 28, 2017 Filed Jan 31, 2017 21:02 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000581 · marketforms-37690.xml · derivative · entry 6 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires 2023-02-12 F1 · derivative.exercise_price: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F1 · shares: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F7 · derivative.exercise_date: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 12, 2016 and the remaining vests monthly thereafter. F1 · derivative.underlying_shares: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F1 · balance_after: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. Read SEC document |
| January 28, 2017 Filed Jan 31, 2017 21:02 UTC | Varex Imaging Corp VREX · Entity 5135 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000581 · marketforms-37690.xml · derivative · entry 5 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires 2022-02-13 F1 · derivative.exercise_price: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F1 · shares: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F6 · derivative.exercise_date: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 13, 2015 and the remaining vests monthly thereafter. F1 · derivative.underlying_shares: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F1 · balance_after: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.